Eledon Pharmaceuticals, Inc. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Eledon Pharmaceuticals, Inc. (ELDN) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $15.88 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2025-11-14
- Eledon Pharmaceuticals, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2024-09-30 was $15.88M.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month as first filed | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month as first filed |
|---|---|---|---|---|
| 2024-09-30 | $15.88M 10-Q · filed 2025-11-14 | $22.54M 10-Q · filed 2024-11-12 | $2.03M 10-Q · filed 2025-11-14 | $2.88M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |